Article

Superior vena cava reconstruction using bovine jugular vein conduit.

Department of Thoracic and Cardiovascular Surgery, Second Xiangya Hospital, Central South University, 410011 Hunan, People's Republic of China.
European Journal of Cardio-Thoracic Surgery (impact factor: 2.55). 12/2007; 32(5):816-7. DOI:10.1016/j.ejcts.2007.07.023
Source: PubMed

ABSTRACT The glutaraldehyde-treated bovine jugular vein conduit (BJVC) is a xenograft conduit initially used for right ventricular outflow tract reconstruction and has never been used for reconstruction of superior vena cava (SVC). In September 2003, a patient with SVC obstruction underwent SVC reconstruction using BJVC. He has been alive for 42 months and free from signs and symptoms of SVC obstruction except that metastasis was found in the vertebrae. The radionuclide venography showed the graft tube was patent and only slight stenosis was found in the proximal anastomosis. The initial result supports BJVC as an acceptable alternative for SVC reconstruction.

0 0
 · 
0 Bookmarks
 · 
31 Views
  • Source
    Article: Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds.
    Qi Tan, Hao Tang, Jianguo Hu, Yerong Hu, Xinmin Zhou, Yunming Tao, Zhongshi Wu
    [show abstract] [hide abstract]
    ABSTRACT: Regeneration deficiency is one of the main obstacles limiting the effectiveness of tissue-engineered scaffolds. To develop scaffolds that are capable of accelerating regeneration, we created a heparin/chitosan nanoparticle-immobilized decellularized bovine jugular vein scaffold to increase the loading capacity and allow for controlled release of vascular endothelial growth factor (VEGF). The vascularization of the scaffold was evaluated in vitro and in vivo. The functional nanoparticles were prepared by physical self-assembly with a diameter of 67-132 nm, positive charge, and a zeta potential of ∼30 mV and then the nanoparticles were successfully immobilized to the nanofibers of scaffolds by ethylcarbodiimide hydrochloride/hydroxysulfosuccinimide modification. The scaffolds immobilized with heparin/chitosan nanoparticles exhibited highly effective localization and sustained release of VEGF for several weeks in vitro. This modified scaffold significantly stimulated endothelial cells' proliferation in vitro. Importantly, utilization of heparin/chitosan nanoparticles to localize VEGF significantly increased fibroblast infiltration, extracellular matrix production, and accelerated vascularization in mouse subcutaneous implantation model in vivo. This study provided a novel and promising system for accelerated regeneration of tissue-engineering scaffolds.
    International Journal of Nanomedicine 01/2011; 6:929-42. · 3.13 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

42 months
 
acceptable alternative
 
BJVC
 
glutaraldehyde-treated bovine jugular vein conduit
 
metastasis
 
proximal anastomosis
 
radionuclide venography
 
slight stenosis
 
superior vena cava
 
SVC
 
SVC obstruction
 
SVC reconstruction
 
ventricular outflow tract reconstruction
 
xenograft conduit
 

Wei-Dong Lü